Algorithme Pharma, an Altasciences company, is now a proud member of the Clinical Data Interchanges Standards Consortium (CDISC), a non-profit organization harmonizing clinical data and streamlining research processes, from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data.
Altasciences is pleased to announce that its companies, Algorithme Pharma (Montreal, Canada) and Vince & Associates Clinical Research (Kansas, USA), are both 2015 CRO Leadership Award recipients.
Last October, Altasciences expanded into the United States with the opening of Algorithme Pharma USA, in Fargo, North Dakota. Today, we are pleased to announce that our first studies were initiated and completed in January, just 91 days from the US contract being signed, and despite the holiday hustle.
In French only - Algorithme Pharma s’est distinguée lors des Grands Prix québécois de la qualité. Le ministre de l'Économie, de l'Innovation et des Exportations, Jacques Daoust, a procédé le 13 novembre à la remise des Grands Prix québécois de la qualité, en compagnie du président du conseil d'administration du Mouvement québécois de la qualité, Roch L. Dubé.
Altasciences is pleased to announce the opening of Algorithme Pharma USA, further expanding the Company’s North American footprint and ability to provide comprehensive Bioequivalence and Phase I/IIa clinical drug development capabilities in the United States.